Sds OpticWAR:SDS 23 EBITDA Margin % is -658.57% as of Mar. 2026. GuruFocus rates WAR:SDS with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Sds Optic ranks worse than 86.89% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sds Optic's EBITDA for the
three
months ended in Mar. 2026 was zł-0.46 Mil. Sds Optic's Revenue for the
three
months ended in Mar. 2026 was zł0.07 Mil. Therefore, Sds Optic's EBITDA margin for the quarter that ended in Mar. 2026 was -658.57%.
Sds Optic (WAR:SDS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sds Optic EBITDA Margin % Related Terms
Sds Optic EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Sds Optic's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:SDS vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Sds Optic's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sds Optic EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sds Optic's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sds Optic's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sds Optic (WAR:SDS) has a EBITDA Margin % of -658.57% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sds Optic and its competitors. According to the industry distribution chart, Sds Optic ranks #709 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 86.9%.
Is Sds Optic's EBITDA Margin % too high?
Sds Optic's current EBITDA Margin % is -658.57%. Based on the distribution chart, Sds Optic ranks #709 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sds Optic has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Sds Optic's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sds Optic ranks #709 out of 816 companies for EBITDA Margin %. This places Sds Optic in the lower half of its industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sds Optic and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sds Optic's current EBITDA Margin % is -658.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sds Optic stock overvalued right now?
Sds Optic (WAR:SDS) has a current EBITDA Margin % of -658.57%. The current EBITDA Margin % is -658.57%. Sds Optic's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sds Optic (WAR:SDS), the current EBITDA Margin % is -658.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sds Optic SA is engaged in developing and creating solutions on the borderline of biochemistry, engineering and fiber optic technologies, used in cancer diagnosis and treatment. The company has designed an Opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. The company is also focused on manufacturing Optoelectronics.
23GF Score
Get the complete analysis for WAR:SDS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SDS has been successfully added to your 
